Clinical observation on acupuncture at points of Shaoyang meridians plus moving cupping on the neck and shoulder for migraine
10.1007/s11726-017-1031-x
- VernacularTitle:针刺少阳经穴联合颈肩部走罐治疗偏头痛的临床疗效观察
- Author:
ling Fang LI
;
yan Ding BI
- Keywords:
Acupuncture Therapy;
Cupping Therapy;
Moving Cupping Therapy;
Migraine Disorders;
Shaoyang Meridians;
Visual Analogue Scale;
Pain Measurement
- From:
Journal of Acupuncture and Tuina Science
2017;15(5):377-381
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe the efficacy of acupuncture at points of Shaoyang meridians plus moving cupping on neck and shoulder for migraine. Methods:A total of 64 migraine cases were randomly allocated into an observation group and a control group, 32 cases in each group. Random number table method was used in allocation. Acupuncture at points of Shaoyang meridians and cupping on neck and shoulder were used for cases in the observation group, which contain acupuncture 5 times a week and cupping once a week. Oral flunarizine hydrochloride capsules were used for cases in the control group, 10 mg for each dose, 1 dose a day. 2 weeks constitutes a course of treatment. The patients were treated for two courses of treatment in both groups. After that, the changes of visual analogue scale (VAS) and the migraine disability assessment questionnaire (MIDAS) were observed, as well as the clinical efficacy. Results:The total effective rate and recovery and marked effective rate in the observation group were 93.8% and 71.0% respectively, versus 78.1% and 43.8% in the control group, showing statistical significant differences (both P<0.05). There were significant decreases in VAS and MIDAS scores after treatments in both groups (both P<0.05). VAS and MIDAS scores in the observation group were significantly different from those in the control group (both P<0.05). Conclusion: Combining acupuncture at points of Shaoyang meridians and cupping on neck and shoulder can relieve headache and reduce influence of migraine on life. It can produce a better efficacy than oral flunarizine hydrochloride capsules in treating migraine patients.
